Depressive pseudodementia and Alzheimer's disease - a pilot study
Kral, V.A.
Der Nervenarzt 53(5): 284-286
1982
ISSN/ISBN: 0028-2804 PMID: 6124891 Document Number: 193392
Document emailed within 1 workday
Related Documents
Barjau Romero, J.M.; Guerro-Prado, D.; Vega Piñero, M. 2001: Depressive pseudodementia: clinico-therapeutical implications Medicina Clinica 117(18): 703-708Uchida, K.; Matsuda, Y.; Nakanishi, A.; Hashimoto, H.; Tagawa, R.; Shimada, A.; Muramatsu, T.; Kawarada, Y.; Yoshida, A.; Higashiyama, S.; Kawabe, J.; Kai, T.; Shiomi, S.; Mori, H.; Inoue, K. 2016: Parahippocampal Atrophy is Associated with Depressive Symptoms in Alzheimer's Disease Osaka City Medical Journal 62(2): 59-67
Patterson, M.B.; Mack, J.L.; Mackell, J.A.; Thomas, R.; Tariot, P.; Weiner, M.; Whitehouse, P.J. 1997: A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. the Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11(Suppl 2): S40-S44
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Szpak, G.M.; Lechowicz, W.; Lewandowska, E.; Bertrand, E.; Wierzba-Bobrowicz, T.; Gwiazda, E.; Schmidt-Sidor, B.; Dymecki, J. 2001: Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study Folia Neuropathologica 39(3): 181-192
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Miyakawa, T. 1988: Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474
Lôo, H.; Daléry, J.; Macher, J.P.; Payen, A. 2003: Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders L'Encephale 29(2): 165-171
Bufill, E.; Blesa, R. 2006: Alzheimer's disease and brain evolution: is Alzheimer's disease an example of antagonistic pleiotropy? Revista de Neurologia 42(1): 25-33
Dudek, D.; Siwek, M.; Borowiecka-Kluza, J. 2008: The analysis of bipolar spectrum features in drug resistant unipolar depression patients as compared to depressive patients who responded to standard antidepressant treatment. a pilot study Psychiatria Polska 42(2): 283-294
Bidzan, L. 1999: Depressive symptoms in the preclinical period of dementia of the Alzheimer's type Psychiatria Polska 33(5): 747-760
Antuono, P.G. 1995: Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group Archives of Internal Medicine 155(16): 1766-1772
Fărcăşel, L. 1988: Current data on the anatomy and physiopathology of Alzheimer's disease (Alzheimer-type senile dementia--ATSD) Revista Medico-Chirurgicala A Societatii de Medici Si Naturalisti Din Iasi 92(2): 289-292
Ng, H.K. 1994: Alzheimer's disease and Alzheimer-type of cerebral degenerations in Chinese Clinical and Experimental Neurology 31: 85-98
Tanna, V.L.; Winokur, G.; Elston, R.C.; Go, R.C. 1976: A linkage study of pure depressive disease: the use of the sib-pair method Biological Psychiatry 11(6): 767-771
Narindrasorasak, S.; Altman, R.A.; Gonzalez-DeWhitt, P.; Greenberg, B.D.; Kisilevsky, R. 1995: An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease Laboratory Investigation; A Journal of Technical Methods and Pathology 72(3): 272-282
DE Felice, F.G.; Houzel, J-Christophe.; Garcia-Abreu, Jé.; Louzada, P.Roberto.F.; Afonso, R.C.; Meirelles, M.Nazareth.L.; Lent, R.; Neto, V.Moura.; Ferreira, Sérgio.T. 2001: Inhibition of Alzheimer's disease β-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy FASEB Journal 15(7): 1297-1299